These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20840378)

  • 1. Economic burden of Parkinson's disease in Singapore.
    Zhao YJ; Tan LC; Li SC; Au WL; Seah SH; Lau PN; Luo N; Wee HL
    Eur J Neurol; 2011 Mar; 18(3):519-26. PubMed ID: 20840378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the lifetime economic burden of Parkinson's disease in Singapore.
    Zhao YJ; Tan LC; Au WL; Heng DM; Soh IA; Li SC; Luo N; Wee HL
    Eur J Neurol; 2013 Feb; 20(2):368-74. PubMed ID: 22978629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of Parkinson's disease among Filipino patients seen at a public tertiary hospital in Metro Manila.
    Prado M; Jamora RD
    J Clin Neurosci; 2020 Apr; 74():41-46. PubMed ID: 31983646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Health-economic burden of Parkinson's disease in Portugal: a cohort study].
    Reese JP; Winter Y; Rosa MM; Rodrigues E Silva AM; von Campenhausen S; Freire R; Mateus C; Balzer-Geldsetzer M; Botzel K; Oertel WH; Dodel R; Sampaio C
    Rev Neurol; 2011 Mar; 52(5):264-74. PubMed ID: 21341221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of Parkinson's disease in eastern Europe: a Czech cohort study.
    Winter Y; von Campenhausen S; Brozova H; Skoupa J; Reese JP; Bötzel K; Eggert K; Oertel WH; Dodel R; Ruzicka E
    Parkinsonism Relat Disord; 2010 Jan; 16(1):51-6. PubMed ID: 19665915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].
    Cubo E; Martínez Martin P; González M; Frades B;
    Neurologia; 2009; 24(1):15-23. PubMed ID: 19003550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
    Wang G; Cheng Q; Zheng R; Tan YY; Sun XK; Zhou HY; Ye XL; Wang Y; Wang Z; Sun BM; Chen SD
    Mov Disord; 2006 Sep; 21(9):1439-43. PubMed ID: 16773620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
    Noyes K; Liu H; Li Y; Holloway R; Dick AW
    Mov Disord; 2006 Mar; 21(3):362-72. PubMed ID: 16211621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of illness and its predictors for Parkinson's disease in Germany.
    Spottke AE; Reuter M; Machat O; Bornschein B; von Campenhausen S; Berger K; Koehne-Volland R; Rieke J; Simonow A; Brandstaedter D; Siebert U; Oertel WH; Ulm G; Dodel R
    Pharmacoeconomics; 2005; 23(8):817-36. PubMed ID: 16097843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of illness in Parkinson's disease.
    Huse DM; Schulman K; Orsini L; Castelli-Haley J; Kennedy S; Lenhart G
    Mov Disord; 2005 Nov; 20(11):1449-54. PubMed ID: 16007641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany.
    Winter Y; Balzer-Geldsetzer M; Spottke A; Reese JP; Baum E; Klotsche J; Rieke J; Simonow A; Eggert K; Oertel WH; Dodel R
    Eur J Neurol; 2010 Sep; 17(9):1156-1163. PubMed ID: 20345926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic impact of Parkinson's disease.
    Findley LJ
    Parkinsonism Relat Disord; 2007 Sep; 13 Suppl():S8-S12. PubMed ID: 17702630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current and projected economic burden of Parkinson's disease in the United States.
    Kowal SL; Dall TM; Chakrabarti R; Storm MV; Jain A
    Mov Disord; 2013 Mar; 28(3):311-8. PubMed ID: 23436720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The health burdens of Parkinson's disease.
    Chrischilles EA; Rubenstein LM; Voelker MD; Wallace RB; Rodnitzky RL
    Mov Disord; 1998 May; 13(3):406-13. PubMed ID: 9613729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the health-related quality of life and economic impact of Parkinson's disease.
    Dowding CH; Shenton CL; Salek SS
    Drugs Aging; 2006; 23(9):693-721. PubMed ID: 17020395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
    Hagell P; Nordling S; Reimer J; Grabowski M; Persson U
    Mov Disord; 2002 Nov; 17(6):1213-20. PubMed ID: 12465059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of illness and care in Parkinson's disease: an evaluation in six countries.
    von Campenhausen S; Winter Y; Rodrigues e Silva A; Sampaio C; Ruzicka E; Barone P; Poewe W; Guekht A; Mateus C; Pfeiffer KP; Berger K; Skoupa J; Bötzel K; Geiger-Gritsch S; Siebert U; Balzer-Geldsetzer M; Oertel WH; Dodel R; Reese JP
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):180-91. PubMed ID: 20888737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the direct and indirect costs associated with Parkinson's disease.
    Rodríguez-Blázquez C; Forjaz MJ; Lizán L; Paz S; Martínez-Martín P
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):889-911. PubMed ID: 26511768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic burden of advanced Parkinson’s disease: an analysis of a UK patient dataset.
    Findley LJ; Wood E; Lowin J; Roeder C; Bergman A; Schifflers M
    J Med Econ; 2011; 14(1):130-9. PubMed ID: 21235405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050.
    Png ME; Yoong J; Phan TP; Wee HL
    BMC Public Health; 2016 Feb; 16():153. PubMed ID: 26880337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.